SCHEMBL17099592

SCHEMBL17099592

NC(=O)CC(c1ccccn1)c1cc2c[nH]nc2cn1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.35
GAA P10253 1/20 0.35
KMT2A Q03164 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ALDH1A1 P00352 2/20 0.35
RAB9A P51151 2/20 0.35
CYP3A4 P08684 1/20 0.35
TSHR P16473 1/20 0.35
CYP2C19 P33261 1/20 0.35
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.34
CACNA1B Q00975 1/20 0.34
ADORA2B P29275 1/20 0.34
CASP1 P29466 1/20 0.33
CHRM2 P08172 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SCN1A P35498 1/20 0.33
SCN2A Q99250 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17597642 0.83 PDE4D (0.38) SMN1; SMN2ALDH1A1LMNA
SCHEMBL17595071 0.75 TBXAS1 (0.44) ALDH1A1LMNA
SCHEMBL2169327 0.74 ALDH1A1 (0.41) ALDH1A1RAB9ACYP3A4TSHRCYP2C19
SCHEMBL17596793 0.73 GAA (0.34) GAAKMT2AALDH1A1KDM4ELMNA
SCHEMBL6227388 0.72 ALDH1A1 (0.53) ALDH1A1RAB9ACYP3A4TSHRCYP2C19
SCHEMBL17592613 0.70 SYK (0.36) SMN1; SMN2ALDH1A1CYP3A4LMNASLC6A2
SCHEMBL6227310 0.70 CYP2C19 (0.55) ALDH1A1RAB9ACYP3A4TSHRCYP2C19
SCHEMBL17099581 0.69 FGFR1 (0.40) MEN1GAAKMT2ASMN1; SMN2ALDH1A1
SCHEMBL5015440 0.68 CYP2C19 (0.41) SMN1; SMN2ALDH1A1RAB9ACYP2C19LMNA
SCHEMBL17099589 0.67 BLM (0.33) SMN1; SMN2RAB9ACYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015143376-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS NIVALIS THERAPEUTICS, INC. (US) 2015-09-24 WO disclosed